What does Medical Information earn in DACH pharma 2026?
On DACH job portals in 2025/26, Medical Information roles typically advertise at €45,000–55,000 (Medical Information Officer), €52,000–68,000 (Medical Information Specialist), €65,000–80,000 (senior specialist) and €72,000–90,000 (Medical Information Manager) in Germany; heads of Medical Information at sponsor affiliates typically reach €90,000–115,000. Austria sits below Germany, Switzerland pays roughly CHF 70,000–125,000 across the same ladder. Sponsor affiliates (Bayer, Roche, Novartis, Boehringer Ingelheim) and CRO/BPO medical information hubs (IQVIA, ICON, Inizio Engage) do most of the hiring. Pharmacists remain the classic entry profile, though physicians, life scientists and science PhDs get hired too — and on both content and pay, the role sits closer to pharmacovigilance than to sales.
What Medical Information actually does — and does not do
Medical Information is the department that answers the question a doctor, pharmacist or patient actually has about one of the company's own medicines: dosing in renal impairment, an interaction with a specific anticoagulant, what the real-world evidence says beyond the package leaflet, whether an off-label use has been studied at all. The channel is phone, email, a web portal or occasionally a letter; the tool is a library of pre-approved standard response documents — and where none exists, a literature search, evaluation and a carefully worded, non-promotional answer, drafted and signed off before it ever reaches the enquirer. Some teams still teach this cycle by its textbook name — define, research, evaluate, synthesise, share — which is a tidier description than most job ads manage. What Medical Information is not: it is not a customer-service call centre that happens to have a pharma logo on the wall, and it is not sales — the entire function is deliberately firewalled from promotional and commercial influence, which is exactly why compliance and legal like having it around. It also sits one desk away from pharmacovigilance: every inquiry is a potential adverse-event report waiting to happen, so Medical Information staff are trained to recognise reportable safety information in any conversation and route it into the PV case-processing clock — without taking over PV's job of assessing and reporting the case itself.
Why Medical Information matters in 2026
Two forces are reshaping the inbox. First, omnichannel HCP engagement has genuinely arrived: inquiries now land through web self-service hubs, chat with human escalation, email and the old-fashioned phone line, and 2026's engagement playbooks talk about one continuous, context-aware conversation across all of them rather than separate silos. Second, and more disruptive: generative AI is becoming a front door to medical information in its own right — one 2025 industry survey put HCP use of generative-AI tools for scientific lookups at just over half of respondents, skewed heavily towards younger clinicians, meaning some questions that used to reach a Medical Information line now get asked of a chatbot first. Inside Medical Information teams, the same technology is turning up as a drafting aid: early pilots at several CROs and sponsors use generative AI to speed up standard-response drafting and literature triage, always with a qualified medical reviewer signing off before anything reaches an HCP — the same human-in-the-loop pattern already showing up in medical writing. None of this replaces the function; a wrong answer to a dosing question is a patient-safety incident, not a typo. It does mean routine volume increasingly routes to self-service or vendor hubs, while in-house teams concentrate on the complex, off-label and safety-adjacent inquiries that actually need a human scientist.
The Medical Information ladder: salary bands DACH 2026
The ladder below shows the German market, where most DACH Medical Information hiring happens. All figures are typically advertised gross annual ranges on DACH job portals and salary-portal averages in 2025/26 — bands, not promises.
| Level | Typical profile | Germany — typically advertised 2025/26 |
|---|---|---|
| Medical Information Officer / Associate | Pharmacist or life-science graduate, first 1–2 years | €45,000–55,000 |
| Medical Information Specialist | 2–4 years, full standard-response and inquiry caseload | €52,000–68,000 |
| Senior Medical Information Specialist | 4–7 years, complex/unsolicited requests, literature strategy | €65,000–80,000 |
| Medical Information Manager | 5–8+ years, team/process lead, often the named Informationsbeauftragter | €72,000–90,000 |
| Senior Manager / Head of Medical Information | 8+ years, DACH or country department head | €90,000–115,000 |
| Next stop: Medical Advisor | HQ medical affairs — see the medical affairs guide | €110,000–140,000+ |
Three honesty notes on that table. One: these are typically advertised ranges for sponsor-affiliate and CRO/BPO roles — product portfolio (prescription vs. OTC), company and city move them. Two: Medical Information tracks close to pharmacovigilance case-processing bands at the lower and middle rungs, and sits meaningfully below MSL and medical affairs pay at every rung — a desk-based, inbound-inquiry function is priced differently to a field or strategy one. Three: general salary portals often blend the specific “Medical Information Manager” title with the broader “Medical Manager” or “Medical Affairs Manager” titles that pay noticeably more — treat those higher averages with suspicion until an offer actually names your title and scope.
Austria advertises somewhat below Germany across the same ladder — roughly €38,000–48,000 at entry to €60,000–90,000 at manager/head level, quoted across 14 payments, so read the offer twice before comparing. Switzerland pays roughly CHF 70,000–90,000 for specialist-level roles and CHF 90,000–125,000 for manager/head roles — comfortably below the CHF 130,000+ that broader medical affairs manager titles command in Zurich or Basel.
The Informationsbeauftragter niche
Buried inside §74a of the German Arzneimittelgesetz (AMG) sits a role most candidates have never heard of until a job ad mentions it in passing: every pharmaceutical company placing finished medicines on the German market must name a person with proven expertise and reliability — the Informationsbeauftragter — who carries personal responsibility for the scientific accuracy of labelling, package leaflets, product information and advertising, and for keeping all of it consistent with the approved marketing authorisation. In practice, the job means reviewing and signing off approval-relevant texts and both promotional and non-promotional materials (including safety letters and training materials), and any appointment or change of Informationsbeauftragter has to be notified to the competent authority. This is not a job-board title you apply for directly — it is a statutory responsibility layered onto an existing senior seat, most often held by a pharmacist or physician with years inside Medical Information, Regulatory Affairs or Medical Affairs, and it is worth raising explicitly at offer stage rather than assuming it is priced in already. Think of it as scientific information's answer to the QPPV concept in pharmacovigilance: a named individual, personally on the hook, though without the QPPV's 24/7 reporting clock.
Who hires Medical Information in DACH
Sponsor affiliates run their own Medical Information desks, typically staffed lean and reserved for complex, specialty or safety-adjacent inquiries: Bayer (Berlin, Leverkusen), Roche (Basel, Grenzach-Wyhlen), Novartis (Basel, Nuremberg), Boehringer Ingelheim (Ingelheim), AstraZeneca (Wedel), GSK (Munich), Merck KGaA (Darmstadt), Sanofi (Frankfurt), MSD (Haar), Daiichi Sankyo (Munich), plus specialty biotech (BioNTech, Vertex, Alnylam). Routine and high-volume inquiry handling increasingly sits with CRO/BPO medical information hubs built for exactly this: IQVIA, ICON (whose Medical Call Centre Services are a named product line), Inizio Engage (the medical-information arm of the former Ashfield), and compliance-and-medical-information providers such as ProPharma Group. A good share of what looks like “sponsor” Medical Information work in DACH is actually delivered this way — vendor-employed, embedded in one sponsor's product portfolio, sponsor-grade training with CRO-grade flexibility — and it is a perfectly respectable way to build the CV.
Realistic entry paths into Medical Information
Pharmacists remain the classic entry profile, and for good reason: prescription-medicine inquiries in particular expect pharmacist- or physician-level scientific literacy, and a community or hospital pharmacy background already means comfort with product information, interactions and dosing questions. Physicians and other life scientists (biology, chemistry, biomedical science) get hired too, especially into OTC-heavy portfolios or with a relevant master's degree. For PhDs leaving academia or bench research, Medical Information is one of the few pharma entry doors that is close to 100% desk-based from day one — no lab bench, and unlike MSL or CRA, no serious travel component — while still using literature-evaluation skills every single day. It is also a recognised feeder into medical affairs, pharmacovigilance and regulatory affairs, because the core skill — reading evidence critically and writing it up under compliance constraints — transfers directly. Turning a pharmacy career or a thesis into an MI-shaped CV is exactly the kind of conversion story a CV & LinkedIn rewrite or a structured coaching programme is built for.
How remote is Medical Information, really?
Genuinely one of the more remote-capable functions in pharma, for the same reason pharmacovigilance is: the work is inbound, desk-based and channel-agnostic, so it travels well to a home office. CRO/BPO medical information hubs place the majority of their case handling close to fully remote by default. Sponsor affiliates have mostly moved to hybrid arrangements since 2024, typically 2–3 office days a week, though rare specialty expertise and some pre-pandemic remote arrangements persist. If travel or field KOL work is what you are actually chasing, that is the MSL fork, not this one; the wider remote landscape across pharma functions is mapped in the remote pharma jobs guide.
Frequently asked questions
What does Medical Information actually do, and is it the same as pharmacovigilance?
Medical Information answers unsolicited and solicited scientific questions from HCPs and patients about a company's own medicines — by phone, email, portal or letter — using pre-approved standard response documents and literature searches, not sales scripts. It is not pharmacovigilance: PV owns adverse-event case processing and reporting deadlines. But every Medical Information channel is also an adverse-event listening post, so staff are trained to spot reportable safety information in any inquiry and route it to PV within the required timelines.
What does Medical Information earn in Germany, Austria and Switzerland in 2026?
Germany: typically advertised €45,000–55,000 (Medical Information Officer) up to €90,000–115,000 (Head of Medical Information); Medical Information Manager sits around €72,000–90,000. Austria advertises somewhat below Germany, roughly €38,000–48,000 to €60,000–90,000 across the same ladder, quoted across 14 payments. Switzerland pays roughly CHF 70,000–90,000 for specialist roles and CHF 90,000–125,000 for manager/head roles. All figures are typically advertised gross ranges from 2025/26 postings and salary-portal averages — bands, not promises.
What is an Informationsbeauftragter, and do I need to become one?
The Informationsbeauftragter is a statutory role under §74a AMG (German Medicines Act): every pharmaceutical company placing finished medicines on the German market must name a person with proven expertise and reliability who is personally responsible for the scientific accuracy of labelling, package leaflets, product information and advertising, and for keeping them consistent with the approved marketing authorisation. It is not an entry-level title — it is usually layered onto a senior Medical Information, Regulatory Affairs or Medical Affairs role, most often held by a pharmacist or physician, and any appointment or change must be notified to the competent authority.
Do I need to be a pharmacist to work in Medical Information?
Not by law for every seat — only the Informationsbeauftragter function itself requires demonstrable expertise and reliability. In practice, pharmacists are the classic entry profile, especially for prescription-medicine inquiries, but physicians, biologists, chemists and other life-science graduates get hired too, and Medical Information is one of the few pharma doors that welcomes PhDs who want a desk-based scientific role without lab work or heavy travel.
Is Medical Information actually remote-friendly in DACH in 2026?
Yes, especially at CRO/BPO medical information hubs (IQVIA, ICON, Inizio Engage and similar), which place case handling close to fully remote by default, mirroring the pattern in pharmacovigilance. Sponsor affiliates have mostly moved to hybrid since 2024, typically 2–3 office days a week. If field or KOL-facing work is what you actually want, that is the MSL fork, not Medical Information.
Will AI replace Medical Information roles?
It is changing the job rather than deleting it. Generative AI is already a genuine competing channel — HCPs increasingly ask AI tools scientific questions directly — and standard-response drafting and literature triage are early candidates for AI-assisted pilots inside Medical Information teams. But a wrong answer to a dosing or safety question is a patient-safety incident, not a typo, so qualified human review stays firmly in the loop for the foreseeable future.